Feinstein Institute

Feinstein researchers nab major NIH awards

Two cutting-edge Feinstein Institute for Medical Research projects have been selected for an elite National Institutes of Health funding program. Kevin Tracey, the institute’s president and CEO, and Ping Wang, Feinstein’s chief scientific officer, will continue their groundbreaking research into bioelectronic medicine and sepsis, respectively, with help from the NIH’s Maximizing Investigators’ Research Awards program. Through the NIH’s National Institute of General Medical Sciences – which supports “basic research that increases understanding of biological processes…


Study is big news for Vagus pioneer Tracey

By GREGORY ZELLER // Medical science has taken an enormous step toward “using electronics to replace drugs.” Kevin Tracey’s words sound downright science-fictional. And no, researchers cannot wave a medical tricorder and instantly cure ailments like “Star Trek” medic “Bones” McCoy. But they’re getting closer to a world where high-tech implants – not pharmaceuticals – are the most effective treatments for inflammatory diseases like rheumatoid arthritis and Parkinson’s disease. A recent clinical trial in the…


Feinstein’s Tracey to head bioelectronics summit

Feinstein Institute chief and global bioelectronics pioneer Kevin Tracey will headline a September New York Academy of Science conference on bioelectronic medicine. Tracey, Feinstein’s president and CEO and the brains behind bioelectronic startup Sanguistat, will share keynote duties with Peder Olofsson, a longtime Feinstein Institute researcher and Wallenberg Academy Fellow at the Karolinska Institutet. The two will headline Key Symposium 2016: Bioelectronic Medicine – Technology Targeting Molecular Mechanisms, presented by the Feinstein Institute, the Royal…


TheraSource snags $3M SBIR grant

By GREGORY ZELLER // A Feinstein Institute-born biotech will tackle radiation poisoning thanks to a grant from the National Institute of Allergy and Infectious Diseases. TheraSource, a Manhasset-based 2004 startup spun out of Northwell Health’s Feinstein Institute for Medical Research, has received a $3 million, three-year Small Business Innovation Research grant from the NIAID, part of the National Institutes of Health. The grant will support the development of an innovative treatment to alleviate physical damage…


Feinstein launching Neural Tourniquet as newco

By GREGORY ZELLER // Meet Sanguistat, the corporate face of the latest technology spinning out of Northwell Health’s Feinstein Institute for Medical Research. For now, Sanguistat is not an Inc. or LLC. But it does have co-founders – Feinstein vice president Christopher Czura, who will be the new company’s chief scientific officer, and Jared Huston, a medical doctor and Feinstein researcher who will serve as chief medical officer. Czura and Huston are also listed as…


The Debrief: Chris Czura has the pulse of the future

Healthcare and data-driven tech are the cornerstones of the innovation economy, making the Feinstein Institute for Medical Research, the R&D wing of the North Shore-LIJ Health System, the public face of Long Island’s best economic hope. More than that, it’s a hotbed of really cool science – and none cooler than the “neural tourniquet,” a nerve-stimulation device that promises to change how doctors staunch blood loss in the field and the operating room. As the…


Battelle superstar to head bioelectronics center

Chad Bouton, an expert in decoding the brain waves that have allowed paralyzed patients to move or operate a wheel chair by thought alone, has been named managing director of the Feinstein Institute’s new Center for Bioelectronic Medicine. The $300 million center, planned for the Nassau Hub area in Uniondale, will bring together scientists and medical experts to research and commercialize non-drug treatments for such conditions as rheumatoid arthritis, diabetes, gastric conditions and others, including…


Answering our ‘pent-up need’ for new industry

By JOHN L. KOMINICKI // A proposed $300 million center on bioelectronic research would get a $50 million jolt if Albany follows recommendations made this week by a group of business and government leaders. The group, which includes both country executives, Long Island Association chief Kevin Law and five other members, was formed to suggest ways to spend $550 million in state funding that has been earmarked for “transformative” projects downstate. Topping their list was a…


A giant step on the road to precision medicine

By GREGORY ZELLER // This is your brain. This is your brain on antipsychotic medications. Any questions? Investigators at the Feinstein Institute for Medical Research, the R&D wing of the North Shore-LIJ Health System, have plenty. Among them: Can doctors use brain scans to predict how patients will respond to antipsychotic medications – even before medications are prescribed? Such predictability would allow providers to fine-tune prescribed meds and doses, a potentially enormous innovation in the…


With VNS, additional strides in controlling epilepsy

By GREGORY ZELLER // Dr. Ashesh Mehta, head of North Shore-LIJ’s epilepsy care center, performed two surgeries on July 24, one fairly routine, one a bit less so. For now, anyway. Both involved VNS, or electrical stimulation of the vagus nerves, the long bundle of fibers connecting the brain and abdomen. The first replaced the battery in an existing vagus-stimulation device implanted in a 30-year-old woman. As surgical procedures go, pure housekeeping, Mehta noted. “After…


Debrief: John Boockvar, Feinstein Institute

John Boockvar has a lot on his mind, most of it regarding your mind. The co-director of the Feinstein Institute’s Brain Tumor Biotech Center is also an investigator in Feinstein’s Laboratory for Brain Tumor and Biology, director of Lenox Hill Hospital’s Brain Tumor Center, director of the Center for Pituitary Surgery and the Acoustic Neuroma Program at the New York Head & Neck Institute and, because he’s swimming in free time, a neurosurgery professor at…


Feinstein, Battelle partner on ‘Neural Tourniquet’

North Shore-LIJ’s Feinstein Institute is partnering with Ohio health giant Battelle on a so-called Neural Tourniquet that will reshape the way doctors staunch blood loss, from the battlefield to the operating room. The technology is an outgrowth of research pioneered by Feinstein director Kevin Tracey, whose discoveries have helped fuel the bioelectronic medicine field, which combines molecular medicine, bioengineering and neuroscience to develop nerve-stimulating and sensing technologies to regulate biological processes. Tracey’s discoveries have already…


Feinstein partnering with Australian pharma

The Feinstein Institute for Medical Research has inked a partnership deal with Novogen, an Australian pharmaceuticals giant and parent company of San Diego-based MEI Pharma, which produces a growing list of anti-cancer drugs already in the clinical stage. The collaboration is intended to develop new pharmaceutical treatments to battle brain cancers, which are currently treated by surgical removal, which traumatizes surrounding healthy brain tissue, and chemotherapy, which is limited by the brain’s natural defenses against…